Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

REVOLUMAB: A Phase II Trial of Nivolumab in Recurrent IDH Mutant High-Grade Gliomas.

Alberto Picca,Mehdi Touat,Lisa Belin,Carole Gourmelon,Vincent Harlay,Stefania Cuzzubbo,Elizabeth Cohen -Jonathan Moyal,Charlotte Bronnimann,Anna Luisa Di Stefano,Isaura Laurent,Julie Lerond,Catherine Carpentier,Franck Bielle,Francois Ducray,Caroline Dehais,Pola Network

EUROPEAN JOURNAL OF CANCER（2024）

Cited 2|Views44
Key words
IDH,High-grade gliomas,Nivolumab,Immunotherapy,Clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined